Boston Scientific Corp. (NYSE:BSX) COO Samuel Leno announced his retirement as executive VP and chief operating officer after three years with med-tech giant.
Leno made the announcement internally on Friday, Oct. 28, according to documents filed with the SEC.
Leno joined Boston Scientific in June 2007 as executive VP of finance and information systems and CFO. In March 2010, he was appointed executive VP and COO.
It’s the latest personnel shakeup in the C-level suites at Boston Scientific, where CEO Ray Elliott retired after the company elevated executive VP Harry Kucheman to interim CEO and named Michael Mahoney as Elliott’s ultimate successor once he’s clear of non-compete deals with former employer Johnson & Johnson (NYSE:JNJ).
During Leno’s tenure on the executive team, he found himself mired in the legal woes surrounding the company’s ill-fated Guidant Corp. acquisition – even though he joined the company after that ill-made acquisition. In the spring of 2010 Leno was named alongside other other BSX execs in a lawsuit alleging that they made calculated, falsely rosy statements about the Guidant cardiac rhythm management division in order to artificially boost stock prices. They and the firm beat the rap when a federal judge dismissed the suit in September, ruling that BSX seemed "diligent, rather than fraudulent or reckless" in its handling of the CRM disaster it inherited with the 2006 acquisition.
Leno plans to leave the company by the end of this year, according to the SEC filing.
BSX shares are so far unchanged by the news, and the company has yet to issue a formal press release.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- OmniGuide names new president & CEO
Cambridge, Mass.-based OmniGuide Inc., a privately held medical device company, appointed industry veteran Scott Flora as its president & CEO and member of the board of directors, according to a press release.
- KCI appoints Franz new VP of global clinical & medical affairs
Kinetic Concepts, Inc. (NYSE:KCI) named Michael Franx vice president of global clinical & medical affairs for LifeCell, KCI’s regenerative medicine business unit.
- AtriCure’s VP of engineering & product development steps down
AtriCure Inc. (NSDQ:ATRC) VP of engineering and product development Salvatore Privitera resigned his post as of October 5, according to SEC filings.
- Insulet adds to its board of directors
Insulet Corp. (NASDAQ:PODD) appointed industry veteran Daniel Levangie to its board of directors.
- Grove Instruments welcome David Harlan
Worcester, Mass.-based Grove Instruments Inc. announced the addition of David Harlan of the University of Massachusetts School of Medicine to its Scientific Advisory Board.
- Zonare appoints PJ Ryland as new VP
Ultrasound maker Zonare Medical Systems Inc., promoted industry veteran PJ Ryland to its vice president of business development & corporate accounts.
- CardioNet’s chairman of the board resigns
CardioNet, Inc.’s (NASDAQ:BEAT) chairman of the board, Randy Thurman, resigned. Board member Kirk Gorman will replace him.
- CaridianBCT head elected chairman of National Blood Foundation
The National Blood Foundation elected as chairman of its board of trustees David Perez, president & CEO of CaridianBCT and Terumo Transfusion (soon to become Terumo BCT) and chairman of the Terumo Blood Management Business Board, according to a press release.
- NewCardio board vice chairman resigns
NewCardio Inc.’s vice chairman of the board Branislav Vajdic resigned his position, according to SEC filings.
- Barrx Medical’s Barrett replaces Timothy O’Shea on Cutera board
Gregory Barrett, president & CEO of Barrx Medical, Inc. replaced Cutera director Timothy O’Shea as a member of the board’s compensation committee.
- Vicor Technologies appoints Kersey to serve as director
Victor Technologies, Inc. appointed Yes Medical LLC’s Andrew Kersey to serve as a class III director.
- Xeltis names Grandidier CEO
Biomedical technology company Xeltis named Laurent Grandidier as its new chief executive officer.
- Volcano Corp. adds two to board of directors
Precision guidance therapy tool maker Volcano Corp (NASDAQ:VOLC) appointment Leslie Norwalk and Eric Topol to its board of directors.